Polychlorinated dibenzodioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), and polychlorinated biphenyls (PCBs) constitute a group of polyhalogenated aromatic hydrocarbons that are persistent, widespread environmental contaminants, frequently detected at parts-per-trillion levels (lipid basis) in animals and humans throughout the industrialized world ([@b30-ehp0112-001289]). 2,3,7,8-Tetrachlorodibenzo-*p*-dioxin (TCDD or dioxin) is the most toxic congener within this group of compounds and has been shown to cause a wide variety of effects in animals, including altered reproductive development \[[@b2-ehp0112-001289], [@b3-ehp0112-001289]; International Agency for Research on Cancer [@b20-ehp0112-001289]\]. Increasing evidence suggests that exposure to TCDD during earlier stages of development is particularly hazardous to reproductive development ([@b5-ehp0112-001289]). *In utero* and lactational TCDD exposure in rodents has been associated with delays in pubertal development \[e.g., delayed vaginal opening, altered vaginal estrous cyclicity ([@b14-ehp0112-001289]; [@b29-ehp0112-001289])\] and effects on ovarian function ([@b14-ehp0112-001289]; [@b17-ehp0112-001289]), even at doses below those that induce overt maternal toxicity. A similar spectrum of reproductive alterations has been associated in rodents exposed *in utero* to other dioxin-like compounds, including PCDDs, PCDFs, and PCBs ([@b12-ehp0112-001289]; [@b16-ehp0112-001289]; [@b25-ehp0112-001289]; [@b27-ehp0112-001289]).

To date, no epidemiologic studies have examined the association of TCDD exposure and age at menarche. Three studies, however, have examined the relation of dioxin-like compounds to pubertal development, with inconsistent conclusions. A study of daughters of Michigan women who had consumed polybrominated biphenyls (PBBs) in food in 1973 found earlier menarche in daughters whose mothers had higher serum PBB levels ([@b4-ehp0112-001289]). There were no differences in age at menarche in Taiwanese women who were exposed postnatally (but premenarche) to PCBs and PCDFs via consumption of contaminated rice oil (Yucheng) compared with unexposed women ([@b15-ehp0112-001289]). In Flemish adolescents, although breast development was inversely related, there was no relation of age at menarche to current serum levels of dioxin-like compounds as measured by chemical-activated luciferase gene expression bioassay toxic equivalents (CALUX-TEQ) or individual PCB congeners 118, 153, and 180 ([@b7-ehp0112-001289]).

On 10 July 1976, as a result of a chemical explosion, residents of Seveso, Italy, experienced the highest levels of TCDD exposure in a human population. Shortly after the explosion, a cohort of residents was established and exposure status was classified by zone of residence (A, B, R, non-ABR) as determined by surface soil TCDD measurements ([@b8-ehp0112-001289]). Twenty years after the explosion, we initiated the Seveso Women's Health Study (SWHS) to measure TCDD in previously stored blood samples and to assess associations of serum levels of TCDD with reproductive disease.

In the SWHS, we have observed that serum TCDD levels were associated with an increase in menstrual cycle length among those who were premenarcheal at exposure, but not in those who were postmenarcheal at exposure ([@b11-ehp0112-001289]). Consistent with animal studies ([@b5-ehp0112-001289]), this suggests that females may be particularly susceptible to the effects of TCDD during early stages of development, for example, *in utero* or prepubertal exposure. In this article we report the results of the association of individual serum TCDD and age of menarche among women who were premenarcheal in 1976, at the time of the explosion.

Materials and Methods
=====================

Study population.
-----------------

Women eligible for the SWHS were 1 month to 40 years of age in 1976, had resided in one of the most highly contaminated zones (A or B), and had adequate stored sera collected soon after the explosion. Enrollment began in March 1996 and ended in July 1998. Of 1,271 eligible women, 17 could not be located or contacted, 33 had died or were too ill to participate, and 240 declined to participate, leaving 981 women. The age distribution of those who declined to participate was not significantly different from those who did participate. For this analysis, we included all women who were premenarcheal on 10 July 1976, the date of the explosion (*n* = 282).

Procedure.
----------

The institutional review boards of the participating institutions approved the study. Details of the study have been presented elsewhere ([@b10-ehp0112-001289]). Briefly, participation included signed informed consent, blood draw, personal interview, and for most women, a gynecologic examination and ultrasound. The interview was conducted by a trained nurse-interviewer who was blinded to serum TCDD levels and zone of residence. Age at menarche was determined from the question, "At what age did you get your first menstrual period?"

Laboratory analyses.
--------------------

TCDD was measured in archived sera by high-resolution gas chromatography/high-resolution mass spectrometry methods ([@b26-ehp0112-001289]). Values are reported on a lipid-weight basis in parts per trillion ([@b1-ehp0112-001289]).

Details of serum sample selection have been presented elsewhere ([@b10-ehp0112-001289]). For the 282 women in this analysis, we measured TCDD in sera collected between 1976 and 1977 for 257 women, between 1978 and 1981 for 23 women, and in 1996 for two women whose earlier samples had insufficient volume. For women with detectable post-1977 TCDD measurements (*n* = 20), the TCDD exposure level was back-extrapolated to 1976 using the Filser model ([@b21-ehp0112-001289]). For nondetectable values (*n* = 22), a serum TCDD level equal to one-half the detection limit was assigned ([@b18-ehp0112-001289]). For the median serum sample weight of 0.65 g, the median detection limit was 18.8 ppt, lipid adjusted.

Statistical analyses.
---------------------

We considered serum TCDD both as a continuous variable (log~10~ TCDD) and a categorical variable. TCDD was first categorized into quartile groups (≤ 55.9, 56--140.2, 140.3--300, \> 300 ppt). Because the lower limit of the serum TCDD level was relatively high, the lowest group was subdivided into women with levels ≤ 20.0 and 20.1--55.9 ppt. We selected 20 ppt (body burden \~ 4 ng/kg) as the cutoff point because this was the average TCDD level of 1976 serum pools collected from Italian women living in an unexposed area ([@b9-ehp0112-001289]). For additional analyses, we categorized preexplosion experience as "unexposed."

Statistical analyses were performed using Cox survival models in Stata 7 (Stata Corporation, College Station, TX, USA). We did not censor data because for each woman age of menarche was observed. Each woman was entered into the denominator ("risk set") for her year-group at the date of the accident or on her seventh birthday, whichever was later.

The Cox model assesses effects on age-specific probabilities of beginning menstruation by the relative hazard, or hazard ratio (HR), the ratio of probabilities computed for each categorized level of exposure versus the reference group or for the effect of a 10-fold increase in TCDD (log~10~ TCDD). For the categorical analysis, we used the highest dose group (\> 300 ppt) as the reference group because the lowest dose group (≤ 20 ppt) had the smallest sample size. We report model-free standard errors, which are valid even when conventional assumptions for regressions are violated ([@b19-ehp0112-001289]). We examined the effect of potential confounders and effect modifiers, including height, weight, body mass index (BMI), and report of participation in athletic training at the time of interview (we did not obtain this information for early time periods), and smoking and alcohol consumption habits between 10 and 14 years of age.

The Cox model with constant HR may not be plausible when there is an inevitable event and the age-specific rates increase to 100%. We therefore also considered parametric regression survival-time models in which the natural log of the age at menarche is expressed as a linear function of the covariates.

The youngest age at menarche reported by the women who were premenarcheal at the time of the explosion was 8 years. We addressed the possibility of bias associated with the inclusion of women who, relative to their birth cohort, might already be at risk for late age at menarche at the time of the explosion (e.g., a woman who was 14 years of age but still premenarcheal in 1976). We therefore repeated the analysis on the subset of 158 women who were \< 8 years of age at the time of the explosion and who were presumably not yet at risk for menarche.

To further assess the possibility of bias, we added to the analysis data 153 women who were in the same birth cohort as the 282 women in the analysis sample (birth years 1959--1976) but who had begun menstruating before the explosion date, 10 July 1976. These 153 women would have been at risk for menarche after the explosion had they not reached menarche before the explosion; their premenarche ages are all "unexposed." For the enlarged sample of 435 (153 + 282) women, we repeated the analysis with this additional "unexposed" exposure category (unexposed, ≤ 20, 20.1--55.9, 56.0--140.2, 140.3--300, and \> 300 ppt) and each "unexposed" woman entered the denominator on her seventh birthday.

Results
=======

Demographic characteristics of the 282 women who were premenarcheal at exposure are presented in [Table 1](#t1-ehp0112-001289){ref-type="table"}. On 10 July 1976, the age of the 282 women was 6.9 ± 3.7 years (mean ± SD; range = 0--17 years), and 158 (56%) were \< 8 years of age. The mean age at menarche reported for the 282 women was 12.8 ± 1.6 year. The mean age at follow-up (1996--1998) was 27.3 ± 3.8 years and the mean BMI was 21.4 ± 3.1 mg/kg^2^. Women who had higher current BMIs or who consumed alcohol or smoked regularly between 10 and 14 years of age reported earlier ages of menarche.

Serum TCDD levels are presented in [Table 2](#t2-ehp0112-001289){ref-type="table"} by reported age at menarche for all premenarcheal women (*n* = 282) and for women who were \< 8 years of age (*n* = 158) at exposure. The median serum TCDD level was 140.3 ppt (range, 3.6--56,000 ppt) for all premenarcheal women and 205.0 ppt (range, 3.6--56,000 ppt) for those who were \< 8 years of age at exposure. Serum TCDD levels did not vary by reported age of menarche for either group \[*p* \> 0.5, analysis of variance (ANOVA)\].

Results of Cox models are presented in [Table 3](#t3-ehp0112-001289){ref-type="table"}. When we examined the effect of potential confounders and effect modifiers, we found no variables to confound (i.e., change the TCDD parameter estimate by \> 10%) or to modify the association between TCDD and age of menarche. Thus, we report unadjusted results. When log~10~ TCDD was entered as the exposure variable, the HR associated with a 10-fold increase in TCDD was 0.95 \[95% confidence interval (CI), 0.83--1.09\]. That is, there was no change in risk of onset of menarche with a 10-fold increase in TCDD levels (e.g., 10--100 ppt). When the analysis was restricted to women \< 8 years of age at exposure, the HR associated with a 10-fold increase in TCDD was 1.08 (95% CI, 0.89--1.30).

When TCDD was categorized ([Table 3](#t3-ehp0112-001289){ref-type="table"}), there was also no evidence of a dose--response trend (*p* = 0.65). None of the four lower exposure groups (≤ 20.0, 20.1--55.9, 56--140.2, 140.3--300 ppt) had significantly different age-specific menarche rates than the highest category (\> 300 ppt), and all CIs for the HR contained 1.0. The conclusions were similar when the analysis was restricted to women who were \< 8 years of age at the time of the explosion. The conclusion of no association of age at menarche and TCDD persisted when we applied alternative models (log-normal, log-logistic) in which the mean of the log of age at menarche was the response (results not shown).

Finally, the analysis of all 435 women in the 1959--1976 birth cohort, with preexplosion ages categorized as "unexposed" also showed no association of TCDD level and age-specific hazard of menarche (data not shown).

Discussion
==========

The results of this study of women residing in Seveso, Italy, in 1976 at the time of an explosion that released high levels of TCDD provide little evidence of an association of exposure and age of menarche. That is, we found no evidence of an association between TCDD levels measured in serum collected near the time of exposure among the 282 women who were premenarcheal at the time of the explosion, the subset of 158 women who were \< 8 years of age at the time of the explosion, or the 435 women who belonged to the 1959--1976 birth cohort.

A limitation of our study is the retrospective recall of age of menarche. However, moderate to high correlations between actual and recalled menarche have been reported for females up to 19 years of age after the event ([@b24-ehp0112-001289]). In our study, the time between onset of menarche and study interview ranged from 5 to 19 years. The women in the SWHS reported age at menarche in whole years, presumably age at last birthday, and age was not rounded to the nearest "biological age." Such nondifferential measurement error would reduce precision and would tend to bias our findings toward no effect.

A second limitation of the present study is that members of the lowest TCDD exposure group (≤ 20 ppt) experienced relatively high serum levels in comparison with contemporary levels reported for this area (\~ 2 ppt) (Warner M, unpublished data). If there is a threshold for TCDD effects on age of onset of menarche but it is \< 20 ppt, we would not be able to detect it in this population. However, we also found no association in analyses that counted preexplosion experience as "unexposed."

Another limitation of this study is that, although the explosion resulted in exposure specifically to TCDD, analyses of pooled serum from residents of an unexposed zone suggest there was substantial background exposure to other PCDDs, PCDFs, and PCBs during this time period \[80 ppt TCDD toxic equivalents (TEQ), on average\] ([@b9-ehp0112-001289]). Therefore, individuals with TCDD levels \< 20 ppt might still have had substantial total TEQ exposure. Because we considered only TCDD in this study, our results may have underestimated an effect due to total TEQ exposure.

An advantage of this study over previous studies is that we were able to measure TCDD levels in individual serum samples collected near the time of exposure. Previous studies have used cross-sectional exposure measures ([@b7-ehp0112-001289]) or had to rely upon alternative exposure assessment methods including ecologic measures ([@b15-ehp0112-001289]) or modeling ([@b4-ehp0112-001289]).

Our finding of no association of TCDD with age at menarche is consistent with results reported in studies with postnatal exposure to other dioxin-like compounds, including PCBs and PCDFs ([@b7-ehp0112-001289]; [@b15-ehp0112-001289]). However, our results differ from those of [@b4-ehp0112-001289], which, in contrast to animal studies, showed an earlier rather than later age of menarche with *in utero* and perinatal PBB exposure. There are several reasons why our results may differ. The PBB studied by [@b4-ehp0112-001289], 2,2′,4,4′,5,5′-hexabromobiphenyl, which was the main congener (60--80%) in the Fire Master mixture, is not a dioxin-like congener and does not bind to the aryl hydrocarbon receptor, unlike coplanar PBBs ([@b6-ehp0112-001289]). Second, the PBB-exposed cohort was exposed *in utero* and via lactation, unlike the SWHS cohort, in whom no exposure occurred *in utero* and only three women reported having been breast-fed postexplosion. It is possible that the fetus is more sensitive to the effects of exposure to dioxin-like compounds *in utero*. In fact, although *in utero* and lactational TCDD exposure in animal studies has been associated with significant effects on onset of puberty ([@b14-ehp0112-001289]; [@b29-ehp0112-001289]) and ovarian function ([@b14-ehp0112-001289]; [@b17-ehp0112-001289]), the evidence for these adverse effects after only postnatal exposure is limited, based on studies using the immature intact and immature hypophysectomized rat models ([@b13-ehp0112-001289]; [@b22-ehp0112-001289], [@b23-ehp0112-001289]; [@b28-ehp0112-001289]). Thus, postnatal (but prepubertal) TCDD exposure experienced by the SWHS cohort, although substantial in dose, likely missed the critical window for exposure effects.

In summary, we have shown that individual serum TCDD measurements are not significantly related to age at menarche among women in the SWHS cohort. The women in this study experienced substantial TCDD exposure during the postnatal but prepubertal developmental period. Given that animal evidence suggests *in utero* exposure has the most significant effect on onset of puberty, continued follow-up of the offspring of the SWHS cohort is important.

###### 

Distribution and age of menarche by select characteristics of women who were premenarcheal at exposure, SWHS, Seveso, Italy, 1996--1998.

                                                             Age at menarche (years)   
  ----------------------------------- ----------- ---------- ------------------------- --------------------------------------------------
  Total                               282 (100)   158 (56)   12.8 ± 1.6                12.5 ± 1.5
  Age at exposure (years)                                                              
   0--4                               84 (30)     84 (53)    12.6 ± 1.5                12.6 ± 1.5
   5--7                               74 (26)     74 (47)    12.4 ± 1.6                12.4 ± 1.6
   8--10                              69 (24)     0 (0)      12.4 ± 1.3                [---](#tfn1-ehp0112-001289){ref-type="table-fn"}
   11--17                             55 (20)     0 (0)      13.8 ± 1.5                [---](#tfn1-ehp0112-001289){ref-type="table-fn"}
  Year of birth                                                                        
   1959--1966                         93 (33)     0 (0)      13.3 ± 1.5                [---](#tfn1-ehp0112-001289){ref-type="table-fn"}
   1967--1970                         90 (32)     59 (37)    12.4 ± 1.6                12.6 ± 1.7
   1971--1976                         99 (35)     99 (63)    12.5 ± 1.4                12.5 ± 1.4
  Zone of residence                                                                    
   A                                  58 (21)     37 (23)    13.0 ± 1.8                12.6 ± 1.2
   B                                  224 (79)    121 (77)   12.7 ± 1.5                12.5 ± 1.6
  Current BMI (kg/m^2^)                                                                
   \< 19.8                            93 (33)     63 (40)    13.2 ± 1.6                13.1 ± 1.6
   19.8--26                           166 (60)    87 (55)    12.6 ± 1.5                12.2 ± 1.4
   26--29                             12 (4)      5 (3)      12.5 ± 2.5                11.4 ± 1.9
   \> 29                              8 (3)       2 (1)      12.4 ± 1.1                12.0 ± 1.4
  Physical activity                                                                    
   No                                 117 (42)    55 (35)    12.7 ± 1.5                12.1 ± 1.5
   Yes                                165 (58)    103 (65)   12.8 ± 1.6                12.8 ± 1.5
  Alcohol use at 10--14 years                                                          
   No                                 271 (96)    153 (97)   12.8 ± 1.5                13.0 ± 1.5
   Yes                                11 (4)      5 (3)      11.8 ± 1.7                12.0 ± 2.5
  Cigarette smoking at 10--14 years                                                    
   No                                 273 (97)    153 (97)   12.9 ± 1.6                12.7 ± 1.5
   Yes                                9 (3)       5 (3)      12.6 ± 1.4                12.2 ± 1.5

---, No observations.

###### 

Frequency (%) of age of menarche and serum TCDD levels (ppt) of women who were premenarcheal at exposure, SWHS, Seveso, Italy, 1996--1998.

          All premenarcheal women in 1976   Women \< 8 years in 1976               
  ------- --------------------------------- -------------------------- ----------- ------------------
  \< 11   16 (6)                            183.5 (107--292)           13 (8)      167.0 (96--244)
  11      36 (13)                           109.7 (42--323)            22 (14)     231.5 (84--553)
  12      83 (29)                           122.0 (45--288)            48 (30)     179.0 (59--477)
  13      56 (20)                           207.5 (74--324)            32 (20)     221.5 (78--403)
  14      62 (22)                           135.0 (51--214)            27 (17)     176.0 (128--407)
  \> 14   29 (10)                           136.0 (51--340)            16 (10)     163.0 (50--570)
  Total   282 (100)                         140.3 (56--300)            158 (100)   205.0 (76--417)

IQR interquartile range.

ANOVA, *p* = 0.64.

ANOVA, *p* = 0.97.

###### 

Age at menarche (mean ± SD) of women who were premenarcheal at exposure and Cox proportional hazards estimates, SWHS, Seveso, Italy, 1996--1998.

                  All premenarcheal women in 1976   Women \< 8 years in 1976                                              
  --------------- --------------------------------- -------------------------- ------------------- --------- ------------ -------------------
  Log~10~TCDD     282                               12.8 ± 1.6                 0.95 (0.83--1.09)   158       12.5 ± 1.5   1.08 (0.89--1.30)
  TCDD (ppt)                                                                                                              
   ≤ 20           24 (8)                            13.1 ± 1.7                 1.11 (0.75--1.64)   8 (5)     13.0 ± 2.0   0.76 (0.40--1.44)
   20.1--55.9     47 (17)                           12.7 ± 1.4                 1.10 (0.83--1.45)   21 (13)   12.7 ± 1.6   0.94 (0.61--1.43)
   56.0--140.2    70 (25)                           12.8 ± 1.4                 1.14 (0.90--1.42)   27 (17)   12.2 ± 1.4   1.20 (0.87--1.64)
   140.3--300.0   72 (26)                           12.6 ± 1.7                 1.07 (0.85--1.35)   50 (32)   12.4 ± 1.8   1.01 (0.75--1.35)
   \> 300.0       69 (24)                           12.8 ± 1.6                 1.00                50 (33)   12.7 ± 1.3   1.00

CI, confidence interval.
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